Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64
Acknowledgments
Reference
- Iwaszko, M.; Świerkot, J.; Kolossa, K.; Jeka, S.; Wiland, P.; Bogunia-Kubik, K. Influence of NKG2D genetic variants on response to anti-TNF agents in patients with Rheumatoid Arthritis. Genes 2018, 9, 64. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Iwaszko, M.; Świerkot, J.; Kolossa, K.; Jeka, S.; Wiland, P.; Bogunia-Kubik, K. Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes 2018, 9, 94. https://doi.org/10.3390/genes9020094
Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K. Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes. 2018; 9(2):94. https://doi.org/10.3390/genes9020094
Chicago/Turabian StyleIwaszko, Milena, Jerzy Świerkot, Katarzyna Kolossa, Sławomir Jeka, Piotr Wiland, and Katarzyna Bogunia-Kubik. 2018. "Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64" Genes 9, no. 2: 94. https://doi.org/10.3390/genes9020094
APA StyleIwaszko, M., Świerkot, J., Kolossa, K., Jeka, S., Wiland, P., & Bogunia-Kubik, K. (2018). Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes, 9(2), 94. https://doi.org/10.3390/genes9020094